{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:04:15Z","timestamp":1790280255937,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2021\/41\/B\/NZ4\/02797"],"award-info":[{"award-number":["2021\/41\/B\/NZ4\/02797"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118396","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:49:23Z","timestamp":1787755763000},"page":"118396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Targeting peptidylarginine deiminases 2 and 4 in diabetic kidney disease: mechanistic rationale and preclinical evidence"],"prefix":"10.1016","volume":"254","author":[{"given":"Wiktoria","family":"Mallek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Wr\u00f3blewska-Schmude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8335-3431","authenticated-orcid":false,"given":"Adam","family":"Lesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Piwkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Wysocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118396_b0005","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA Consensus Conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2026.118396_b0010","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Disease","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2026.118396_b0015","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0020","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bcp.2026.118396_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.124038","article-title":"NETosis in diabetic kidney disease: molecular mechanisms and therapeutic opportunities","volume":"382","author":"Mourya","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118396_b0040","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2026.2657629","article-title":"Preclinical characterization of AZD1163, a first-in-class anti-PAD2\/4 bispecific antibody for the treatment of rheumatoid arthritis","volume":"18","author":"Sims","year":"2026","journal-title":"MAbs"},{"key":"10.1016\/j.bcp.2026.118396_b0045","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165654","article-title":"Molecular pathways that drive diabetic kidney disease","volume":"133","author":"Mohandes","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118396_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bip.22127","article-title":"The protein arginine deiminases: structure, function, inhibition, and disease","volume":"99","author":"Bicker","year":"2013","journal-title":"Biopolymers"},{"key":"10.1016\/j.bcp.2026.118396_b0055","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease","volume":"25","author":"Vossenaar","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.bcp.2026.118396_b0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","article-title":"Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages","volume":"63","author":"Vossenaar","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2026.118396_b0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nsmb799","article-title":"Structural basis for Ca2+-induced activation of human PAD4","volume":"11","author":"Arita","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.118396_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12950-022-00317-8","article-title":"Protein arginine deiminase 2 (PAD2) modulates the polarization of THP-1 macrophages to the anti-inflammatory M2 phenotype","volume":"19","author":"Stachowicz","year":"2022","journal-title":"J. Inflamm. (Lond.)"},{"key":"10.1016\/j.bcp.2026.118396_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134576","article-title":"Peptidylarginine deiminase (PAD): a promising target for chronic disease treatment","volume":"278","author":"Mansouri","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2026.118396_b0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ymthe.2025.10.009","article-title":"PAD4 promotes macrophage migration to aggravate tubulointerstitial injury in diabetic kidney disease","volume":"34","author":"Xiong","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2026.118396_b0085","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3390\/nu14142965","article-title":"Neutrophil extracellular traps promote NLRP3 inflammasome activation and glomerular endothelial dysfunction in diabetic kidney disease","volume":"14","author":"Gupta","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.118396_b0090","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1172\/JCI97879","article-title":"Bowman\u2019s capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells","volume":"128","author":"Chen","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118396_b0095","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1172\/JCI122045","article-title":"CD8+ cells and glomerular crescent formation: outside-in as well as inside-out","volume":"128","author":"Kitching","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118396_b0100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138873","article-title":"Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis","volume":"5","author":"Tian","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2026.118396_b0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2003.12.038","article-title":"Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6","volume":"330","author":"Chavanas","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2026.118396_b0110","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1021\/acs.biochem.2c00158","article-title":"Molecular mechanism of protein arginine deiminase 2: a study involving multiple microsecond long molecular dynamics simulations","volume":"61","author":"Cicek","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118396_b0115","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/cb500933j","article-title":"Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design","volume":"10","author":"Slade","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118396_b0135","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1021\/bi700095s","article-title":"Protein arginine deiminase 4: evidence for a reverse protonation mechanism","volume":"46","author":"Knuckley","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118396_b0130","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1021\/bi500554b","article-title":"Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism","volume":"53","author":"Dreyton","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118396_b0120","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1021\/jm2008985","article-title":"The development of N-\u03b1-(2-carboxyl)benzoyl-N5-(2-fluoro-1-iminoethyl)-L-ornithine amide (o-F-amidine) and N-\u03b1-(2-carboxyl)benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors","volume":"54","author":"Causey","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118396_b0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2508369122","article-title":"Glycosaminoglycans activate peptidylarginine deiminase 4 by enhancing calcium affinity","volume":"122","author":"Bereta","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118396_b0140","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.1021\/jp903173c","article-title":"Active site cysteine is protonated in the PAD4 Michaelis complex: evidence from Born\u2013Oppenheimer ab initio QM\/MM molecular dynamics simulations","volume":"113","author":"Ke","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bcp.2026.118396_b0145","doi-asserted-by":"crossref","first-page":"16705","DOI":"10.1021\/jp9080614","article-title":"Born\u2013Oppenheimer ab initio QM\/MM molecular dynamics simulations of the hydrolysis reaction catalyzed by protein arginine deiminase 4","volume":"113","author":"Ke","year":"2009","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.bcp.2026.118396_b0150","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-026-02215-8","article-title":"Regulation of calcium homeostasis by S100A12 drives NETosis in chronic kidney disease","volume":"75","author":"Zhu","year":"2026","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2026.118396_b0155","doi-asserted-by":"crossref","first-page":"15228","DOI":"10.1038\/s41598-018-33385-z","article-title":"Evidence for a direct link between PAD4-mediated citrullination and the oxidative burst in human neutrophils","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118396_b0160","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/art.27439","article-title":"Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation","volume":"62","author":"Andrade","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2026.118396_b0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nchembio.1735","article-title":"Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation","volume":"11","author":"Lewis","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118396_b0170","article-title":"Citrullination of NF-\u03baB p65 by PAD2 as a novel therapeutic target for modulating macrophage polarization in acute lung injury","volume":"12","author":"Yu","year":"2025","journal-title":"Adv Sci (weinh)"},{"key":"10.1016\/j.bcp.2026.118396_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aal3062","article-title":"Citrullination of NF-\u03baB p65 promotes its nuclear localization and TLR-induced expression of IL-1\u03b2 and TNF\u03b1","volume":"2","author":"Sun","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bcp.2026.118396_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350942","article-title":"PLC and PAD2 regulate extracellular calcium-triggered release of macrophage extracellular DNA traps","volume":"55","author":"Mishra","year":"2025","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2026.118396_b0185","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1021\/acs.biochem.9b00225","article-title":"Calcium regulates the nuclear localization of protein arginine deiminase 2","volume":"58","author":"Zheng","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118396_b0190","article-title":"Peptidylarginine deiminase 2 in host immunity: current insights and perspectives","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118396_b0195","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41584-020-0409-1","article-title":"PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets","volume":"16","author":"Curran","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2026.118396_b0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118396_b0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/JLB.3RU0620-375R","article-title":"The vitals of NETs","volume":"110","author":"Tan","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2026.118396_b0210","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.123.323897","article-title":"NETosis drives blood pressure elevation and vascular dysfunction in hypertension","volume":"134","author":"Krishnan","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2026.118396_b0215","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118396_b0525","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1073\/pnas.1203280109","article-title":"Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor \u03b1 target gene activation","volume":"109","author":"Zhang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118396_b0220","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.tcb.2022.01.014","article-title":"Insights into peptidylarginine deiminase expression and citrullination pathways","volume":"32","author":"Yu","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bcp.2026.118396_b0225","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00592-014-0676-x","article-title":"NETosis is induced by high glucose and associated with type 2 diabetes","volume":"52","author":"Menegazzo","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.bcp.2026.118396_b0230","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42826-024-00226-2","article-title":"Observation of neutrophil extracellular traps in the development of diabetic nephropathy using diabetic murine models","volume":"40","author":"Jeon","year":"2024","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.bcp.2026.118396_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1202463","article-title":"Diabetes-associated neutrophil NETosis: pathogenesis and interventional target of diabetic complications","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bcp.2026.118396_b0240","article-title":"Emerging role of neutrophil extracellular traps in the complications of diabetes mellitus","volume":"9","author":"Shafqat","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.bcp.2026.118396_b0245","article-title":"Citrullination and PAD enzyme biology in type 1 diabetes \u2014 regulators of inflammation, autoimmunity, and pathology","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118396_b0250","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.3390\/ijms26136113","article-title":"Targeting PAD4: a promising strategy to combat \u03b2-cell loss in type 1 diabetes","volume":"26","author":"Kang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118396_b0255","first-page":"0365","article-title":"Diabetes primes neutrophils for neutrophil extracellular trap formation through trained immunity","volume":"7","author":"Shrestha","year":"2024","journal-title":"Research (wash D c)"},{"key":"10.1016\/j.bcp.2026.118396_b0260","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3389\/fimmu.2017.01200","article-title":"Spontaneous secretion of the citrullination enzyme PAD2 and cell surface exposure of PAD4 by neutrophils","volume":"8","author":"Zhou","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118396_b0265","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1523-1755.2005.00383.x","article-title":"Citrullination preferentially proceeds in glomerular Bowman\u2019s capsule and increases in obstructive nephropathy","volume":"68","author":"Feng","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2026.118396_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1253667","article-title":"NETosis: an emerging therapeutic target in renal diseases","volume":"14","author":"Juha","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118396_b0275","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/kei023","article-title":"Citrullination of fibronectin in rheumatoid arthritis synovial tissue","volume":"44","author":"Chang","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bcp.2026.118396_b0280","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2022.0244","article-title":"Citrullination of matrisomal proteins in health and diseases","volume":"378","author":"Saifi","year":"2023","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bcp.2026.118396_b0285","doi-asserted-by":"crossref","first-page":"14450","DOI":"10.1096\/fj.201900978RR","article-title":"Fibronectin is up-regulated in podocytes by mechanical stress","volume":"33","author":"Kliewe","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2026.118396_b0290","doi-asserted-by":"crossref","first-page":"18119","DOI":"10.1016\/S0021-9258(19)84685-9","article-title":"Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain","volume":"264","author":"Inagaki","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118396_b0295","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1681\/ASN.2019121261","article-title":"LIM-nebulette reinforces podocyte structural integrity by linking actin and vimentin filaments","volume":"31","author":"Ge","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2026.118396_b0300","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00428-005-0134-9","article-title":"Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury","volume":"448","author":"Zou","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bcp.2026.118396_b0305","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/cells9071700","article-title":"Regulation of the actin cytoskeleton in podocytes","volume":"9","author":"Blaine","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118396_b0310","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/ijms25010647","article-title":"Cytoskeleton rearrangement in podocytopathies: an update","volume":"25","author":"Ma","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118396_b0315","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/03009742.2012.670263","article-title":"Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"41","author":"Fan","year":"2012","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bcp.2026.118396_b0320","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.kint.2017.09.021","article-title":"Vinculin is required to maintain glomerular barrier integrity","volume":"93","author":"Lausecker","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2026.118396_b0325","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1021\/acs.biochem.5c00391","article-title":"Isoform-selective PAD2\/PAD4 substrates with unnatural amino acids enable cellular peptidylarginine deiminase activity profiling and reveal vimentin citrullination effects in macrophages","volume":"64","author":"Bereta","year":"2025","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2026.118396_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.782677","article-title":"The CXCL1-CXCR2 axis mediates tubular injury in diabetic nephropathy through the regulation of the inflammatory response","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2026.118396_b0335","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/0008-5472.CAN-21-4045","article-title":"A novel selective inhibitor JBI-589 targets PAD4-mediated neutrophil migration to suppress tumor progression","volume":"82","author":"Deng","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118396_b0340","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12964-024-01565-2","article-title":"Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-\u03baB signaling in diabetic kidney disease","volume":"22","author":"Cui","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.118396_b0345","article-title":"Synergistic effect of mesangial cell-induced CXCL1 and TGF-\u03b21 in promoting podocyte loss in IgA nephropathy","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118396_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154804","article-title":"The IL-8-CXCR1\/2 axis contributes to diabetic kidney disease","volume":"121","author":"Loretelli","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2026.118396_b0355","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4093\/dmj.2024.0504","article-title":"Effects of CXCR1\/2 blockade with ladarixin on streptozotocin-induced type 1 diabetes mellitus and peripheral neuropathy and retinopathy in rat","volume":"49","author":"Boccella","year":"2025","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.bcp.2026.118396_b0360","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.2337\/db22-0153","article-title":"Neutrophil extracellular traps induce glomerular endothelial cell dysfunction and pyroptosis in diabetic kidney disease","volume":"71","author":"Zheng","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2026.118396_b0365","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/13543776.2025.2484366","article-title":"A patent review of peptidylarginine deiminase 4 (PAD4) inhibitors (2014\u2013present)","volume":"35","author":"Aiken","year":"2025","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bcp.2026.118396_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1854078","article-title":"Peptidylarginine deiminase 4-mediated citrullination in human disease: molecular mechanisms and therapeutic targeting","volume":"17","author":"Zou","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118396_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117020","article-title":"Discovery of pentagalloylglucose in Moutan Cortex as a highly potent inhibitor of human peptidyl arginine deiminase 4 (PAD4) by UHPLC-MS\/MS","volume":"265","author":"Zhang","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bcp.2026.118396_b0380","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2281763","article-title":"Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases","volume":"15","author":"van der Linden","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.bcp.2026.118396_b0385","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-8587(15)00261-2","article-title":"The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial","volume":"3","author":"de Zeeuw","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2026.118396_b0390","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0395","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1182\/blood-2014-07-587709","article-title":"PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock","volume":"125","author":"Martinod","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118396_b0400","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0405","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acsmedchemlett.5c00372","article-title":"Peptidylarginine deiminase (PAD) inhibitor optimization through displacement of a trapped water molecule","volume":"16","author":"Schnute","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2026.118396_b0410","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1038\/s41467-025-59919-4","article-title":"Inhibiting peptidylarginine deiminases (PAD1\u20134) by targeting a Ca2+-dependent allosteric binding site","volume":"16","author":"Dakin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118396_b0415","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/acschembio.4c00397","article-title":"Discovery, characterization, and structure of a cell-active PAD2 inhibitor acting through a novel allosteric mechanism","volume":"19","author":"Byrnes","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118396_b0420","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1038\/s41598-023-30246-2","article-title":"Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4","volume":"13","author":"Gajendran","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118396_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716250","article-title":"Applicability of small-molecule inhibitors in the study of peptidyl arginine deiminase 2 (PAD2) and PAD4","volume":"12","author":"Mart\u00edn Monreal","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118396_b0430","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s13046-019-1404-8","article-title":"Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118396_b0435","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302055","article-title":"Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis","volume":"6","author":"Heger","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"#cr-split#-10.1016\/j.bcp.2026.118396_b0440.1","doi-asserted-by":"crossref","unstructured":"D. Sivanandhan, S. Rajagopal, G. Chandru, M. Zainuddin, N. Sadhu, R. Gosu, L. Rastelli, A. Siddiqui, S. Singh, G. Rudresh, S. Mullurwar, S. Kandan, S. Vishwakarma, G. Hallur, R. Trivedi, D.A. Jeyaraj, Novel, isoform selective PAD4 inhibitors for the treatment of cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022","DOI":"10.1158\/1538-7445.AM2022-2646"},{"key":"#cr-split#-10.1016\/j.bcp.2026.118396_b0440.2","doi-asserted-by":"crossref","unstructured":"Apr 8-13, 2022. Philadelphia (PA), AACR. Cancer Res 82 (12 Suppl): Abstract nr 2646, 2022. Numeric potency values appear in the associated conference poster, https:\/\/www.jubilanttx.com\/pdf\/pad4_poster_aacr2022.pdf (accessed July 2026).","DOI":"10.1158\/1538-7445.AM2022-2646"},{"key":"10.1016\/j.bcp.2026.118396_b0445","unstructured":"Jubilant Therapeutics Inc.: Corporate presentation, December 2025. Available at https:\/\/www.jubilanttx.com\/pdf\/jt_corporate_deck.pdf (accessed July 2026)."},{"key":"10.1016\/j.bcp.2026.118396_b0450","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","article-title":"Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin, and vascular disease in lupus-prone MRL\/lpr mice","volume":"74","author":"Knight","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2026.118396_b0455","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0460","doi-asserted-by":"crossref","first-page":"F293","DOI":"10.1152\/ajprenal.00364.2017","article-title":"ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI","volume":"314","author":"Rabadi","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bcp.2026.118396_b0465","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124729","article-title":"Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus","volume":"3","author":"Liu","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2026.118396_b0470","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0475","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0480","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0485","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0495","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118396_b0500","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.kint.2025.10.005","article-title":"REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide","volume":"109","author":"Pruijm","year":"2026","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2026.118396_b0505","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/ijms26041670","article-title":"Anti-inflammatory effects of SGLT2 inhibitors: focus on macrophages","volume":"26","author":"Rykova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118396_b0510","doi-asserted-by":"crossref","first-page":"F1052","DOI":"10.1152\/ajprenal.00243.2014","article-title":"Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury","volume":"307","author":"Ham","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bcp.2026.118396_b0515","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00018-024-05136-z","article-title":"Caspase-11\/GSDMD contributes to the progression of hyperuricemic nephropathy by promoting NETs formation","volume":"81","author":"Wu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.118396_b0520","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000546343","article-title":"Clinical and experimental insights into the role of NETosis in IgA nephropathy pathogenesis","volume":"11","author":"Wang","year":"2025","journal-title":"Kidney Dis (Basel)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:50:16Z","timestamp":1790279416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226007355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":106,"alternative-id":["S0006295226007355"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118396","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting peptidylarginine deiminases 2 and 4 in diabetic kidney disease: mechanistic rationale and preclinical evidence","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118396"}}